Safety First
Release time:
2021-06-11
experience is the most painful learning method. in the past 1-4 months, a total of 6 safety accidents occurred in the group's subordinate enterprises. The causes of these accidents are different, including falling accidents caused by non-compliance with safety management by foreign construction units; slipping and falling accidents caused by failure to wear labor protection articles in accordance with regulations; and vehicle collision accidents caused by non-compliance with traffic rules. There are also 3 accidents caused by illegal operation.
For the safety supervision of foreign construction units, we cannot take a single safety agreement as the whole management, but should give necessary supervision during the whole construction process, to ensure that there must be a person in charge of safety at the construction site, and the person in charge of safety cannot leave the site without special circumstances. If it is found in the supervision process that the internal management of construction personnel is chaotic and there is a high risk of accidents in the construction process, the internal personnel of the enterprise shall be arranged for on-site supervision in the subsequent risk control process.
In the daily work within the enterprise, will we dump the collected waste oil privately because of inertia, such as clearly placing the collected waste oil in the designated location, but in order to take a few steps less? Whether due to bad habits, such as climbing without any safety protection measures, and then illegal construction; When we face other colleagues' illegal operations, if you see a colleague climbing forklifts and stacking there, will he come forward to stop it? What is safety for you and me who are in various jobs in the enterprise? Safety is to live responsibly for yourself and your colleagues.
For these internal staff accidents, although they did not cause serious consequences, it also reflects that our safety management is not in place. Judging from several safety accidents that have occurred since this year, illegal operations are still the main cause of the accidents, while the convenience of doing things and the existence of fluke psychology show that the safety concept in employees' minds has not been firmly established. This requires our managers to always pay attention to safety training and education, so as to make unremitting efforts. Safe process equipment, advanced safety technology and safety management system with rewards and punishments in place play a supporting role in the safety culture of the enterprise. However, only our employees' attitude towards work safety can really promote the safety culture.
Overcome inertia and bad working habits, stop the illegal behavior of colleagues around you in time, and integrate the awareness of safe work into our own cells, just like eating and sleeping. At this moment, please join me in saying "safety first " to yourself and your colleagues around you.
(Ni Zhenyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page